A nurse is preparing to administer 0. 9% sodium chloride IV infusion 1000 mL bag at a rate of 200 mL/hr for a client who has rhabdomyolysis The nurse should expect the IV pump to infuse over how many hr?

(Round the answer to the nearest whole number. Use a leading zero if it applies. not use a trailing zero.)

A) Montelukast:
Montelukast is a leukotriene receptor antagonist (LTRA) used as a controller or maintenance medication for asthma. It is not used for the immediate relief of asthma symptoms during an acute attack. Montelukast is taken regularly to prevent asthma symptoms and reduce the frequency of asthma attacks, but it does not provide rapid relief during an ongoing attack.

B) Fluticasone:
Fluticasone is an inhaled corticosteroid (ICS) used as a controller medication for asthma. It works by reducing airway inflammation and is taken regularly to control asthma symptoms and prevent exacerbations. Fluticasone is not used for the immediate relief of acute asthma symptoms and is not suitable for aborting an ongoing asthma attack.

C) Cromolyn:
Cromolyn is a mast cell stabilizer used as a controller medication for asthma. It helps prevent the release of inflammatory substances that contribute to asthma symptoms. Cromolyn is taken regularly to prevent asthma symptoms and reduce the frequency of asthma attacks but is not used for the immediate relief of acute asthma symptoms like albuterol.

D) Albuterol.
Albuterol is a short-acting beta agonist (SABA) bronchodilator used for the quick relief of asthma symptoms during an acute asthma attack or exacerbation. It works rapidly to relax the smooth muscles in the airways, opening them up and relieving bronchoconstriction, which improves airflow and alleviates symptoms such as wheezing, shortness of breath, and chest tightness. Albuterol is typically administered via inhalation through a metered-dose inhaler (MDI) or a nebulizer.

A) Restlessness.
Restlessness is often one of the earliest signs of shock. It reflects the body's attempt to compensate for decreased tissue perfusion and oxygen delivery by increasing sympathetic nervous system activity. Restlessness may manifest as agitation, fidgeting, or an inability to sit still. It is an important clinical indicator that suggests impending hemodynamic instability and warrants prompt assessment and intervention.

B) Pale skin:
Pale skin is a common sign of shock, but it may not always be the earliest manifestation. Pale skin typically occurs later in the progression of shock as vasoconstriction occurs, redirecting blood flow away from the skin to vital organs in an attempt to maintain perfusion.

C) Complaints of thirst:
While complaints of thirst may indicate dehydration or fluid loss, they are not typically considered the earliest sign of shock. Thirst usually occurs after the body has already begun to experience fluid deficit and may not be apparent until shock is more advanced.

D) Complaints of nausea:
Nausea may occur in shock due to decreased perfusion to the gastrointestinal tract, but it is not usually the earliest sign. Nausea may develop as shock progresses and metabolic disturbances worsen, but it is often preceded by other symptoms such as restlessness or altered mental status.